Question 1

What is Iovance Biotherapeutics Inc (IOVA) stock price today?

Accepted Answer

Iovance Biotherapeutics Inc (IOVA) currently trades at $3.36 per share. The stock has a market capitalization of $1.41B and a P/E ratio of —x.

Question 2

Is IOVA stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Iovance Biotherapeutics Inc has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Iovance Biotherapeutics Inc's revenue and earnings?

Accepted Answer

Iovance Biotherapeutics Inc has trailing twelve-month (TTM) revenue of $263.50M with profit margins of -148.40%. Earnings per share (EPS) is $-1.09.

Question 4

Is IOVA stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Iovance Biotherapeutics Inc's intrinsic value is $2.74, representing a margin of safety of 5.11%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$238000.00	$1.19M	$164.07M	$263.50M	$263.50M
Net income	$-389.92M	$-444.04M	$-372.18M	$-390.98M	$-71.90M
EPS	—	—	—	—	$-1.09
Free cash flow	$-313.18M	$-384.11M	$-364.05M	$-336.24M	$-61.88M
Profit margin	-163,833.19%	-37,345.42%	-226.84%	-148.38%	-148.40%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IOVA	$1.41B	32	5.7	2.0	5.3	5.0	+5.11%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Iovance Biotherapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare